Aduro BioTech Secures $6,500,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=710f2d73-62f0-4ced-8bb9-4801e59dfe09&Preview=1 - Date
1/31/2013 - Company Name
Aduro BioTech - Mailing Address
626 Bancroft Way Berkeley, CA 94710 - Company Description
Aduro BioTech is a clinical-stage immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases. The platform of attenuated and targeted vaccines based on Listeria monocytogenes has been in development for nine years. - Website
http://www.adurobiotech.com - Transaction Type
Venture Equity - Transaction Amount
$6,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
This financing will help fund further execution and expansion of Aduro’s targeted immunotherapy development efforts. - M&A Terms
- Venture Investor
Undisclosed
